Vanda Pharmaceuticals
VNDA
HK$36.73
Share price
-0.43%
Change (1 day)
-21.63%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$0.94 Billion
According to Vanda Pharmaceuticals's latest financial reports the company's total liabilities are HK$0.94 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Vanda Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$0.91 B | 12.97% |
| 2023-12-31 | HK$0.80 B | -3.33% |
| 2022-12-31 | HK$0.83 B | 20.71% |
| 2021-12-31 | HK$0.69 B | 11.47% |
| 2020-12-31 | HK$0.62 B | 9.64% |
| 2019-12-31 | HK$0.56 B | 27.68% |
| 2018-12-31 | HK$0.44 B | -23.23% |
| 2017-12-31 | HK$0.57 B | -5.63% |
| 2016-12-31 | HK$0.61 B | -1.17% |
| 2015-12-31 | HK$0.62 B | 634.49% |
| 2014-12-31 | HK$84.44 M | -89.02% |
| 2013-12-31 | HK$0.76 B | -20.93% |
| 2012-12-31 | HK$0.97 B | -15.99% |
| 2011-12-31 | HK$1.15 B | -15.12% |
| 2010-12-31 | HK$1.36 B | -13.16% |
| 2009-12-31 | HK$1.57 B | 5096.54% |
| 2008-12-31 | HK$30.24 M | -70.46% |
| 2007-12-31 | HK$0.10 B | 38.53% |
| 2006-12-31 | HK$73.91 M | 87.37% |
| 2005-12-31 | HK$39.44 M | 180.66% |
| 2004-12-31 | HK$14.05 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | HK$482.64 B | 50,920.17% | 🇨🇭 Switzerland |
 Eli Lilly LLY | HK$577.25 B | 60,921.08% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$907.08 B | 95,786.96% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | HK$588.53 B | 62,113.43% | 🇺🇸 USA |
 Pfizer PFE | HK$921.43 B | 97,304.56% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | HK$2.18 M | -99.77% | 🇺🇸 USA |
 Merck MRK | HK$523.72 B | 55,262.23% | 🇺🇸 USA |